50% OFF
MarketBeat All Access
Get 30 days free. Save 50% your first year.
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
S&P 500   3,643.27 (-2.04%)
DOW   29,249.23 (-1.46%)
QQQ   271.72 (-2.94%)
AAPL   142.61 (-4.83%)
MSFT   235.29 (-2.40%)
META   137.67 (-2.78%)
GOOGL   96.64 (-3.41%)
AMZN   114.15 (-3.27%)
TSLA   273.16 (-5.09%)
NVDA   121.68 (-4.46%)
NIO   15.90 (-8.25%)
BABA   77.37 (-4.47%)
AMD   64.44 (-5.73%)
T   15.60 (-1.45%)
MU   49.80 (-2.35%)
CGC   2.84 (-6.58%)
F   11.58 (-4.93%)
GE   62.75 (-2.65%)
DIS   97.89 (-1.52%)
AMC   7.29 (-4.95%)
PYPL   89.04 (-2.28%)
PFE   44.08 (-0.79%)
NFLX   243.83 (-0.56%)
S&P 500   3,643.27 (-2.04%)
DOW   29,249.23 (-1.46%)
QQQ   271.72 (-2.94%)
AAPL   142.61 (-4.83%)
MSFT   235.29 (-2.40%)
META   137.67 (-2.78%)
GOOGL   96.64 (-3.41%)
AMZN   114.15 (-3.27%)
TSLA   273.16 (-5.09%)
NVDA   121.68 (-4.46%)
NIO   15.90 (-8.25%)
BABA   77.37 (-4.47%)
AMD   64.44 (-5.73%)
T   15.60 (-1.45%)
MU   49.80 (-2.35%)
CGC   2.84 (-6.58%)
F   11.58 (-4.93%)
GE   62.75 (-2.65%)
DIS   97.89 (-1.52%)
AMC   7.29 (-4.95%)
PYPL   89.04 (-2.28%)
PFE   44.08 (-0.79%)
NFLX   243.83 (-0.56%)
S&P 500   3,643.27 (-2.04%)
DOW   29,249.23 (-1.46%)
QQQ   271.72 (-2.94%)
AAPL   142.61 (-4.83%)
MSFT   235.29 (-2.40%)
META   137.67 (-2.78%)
GOOGL   96.64 (-3.41%)
AMZN   114.15 (-3.27%)
TSLA   273.16 (-5.09%)
NVDA   121.68 (-4.46%)
NIO   15.90 (-8.25%)
BABA   77.37 (-4.47%)
AMD   64.44 (-5.73%)
T   15.60 (-1.45%)
MU   49.80 (-2.35%)
CGC   2.84 (-6.58%)
F   11.58 (-4.93%)
GE   62.75 (-2.65%)
DIS   97.89 (-1.52%)
AMC   7.29 (-4.95%)
PYPL   89.04 (-2.28%)
PFE   44.08 (-0.79%)
NFLX   243.83 (-0.56%)
S&P 500   3,643.27 (-2.04%)
DOW   29,249.23 (-1.46%)
QQQ   271.72 (-2.94%)
AAPL   142.61 (-4.83%)
MSFT   235.29 (-2.40%)
META   137.67 (-2.78%)
GOOGL   96.64 (-3.41%)
AMZN   114.15 (-3.27%)
TSLA   273.16 (-5.09%)
NVDA   121.68 (-4.46%)
NIO   15.90 (-8.25%)
BABA   77.37 (-4.47%)
AMD   64.44 (-5.73%)
T   15.60 (-1.45%)
MU   49.80 (-2.35%)
CGC   2.84 (-6.58%)
F   11.58 (-4.93%)
GE   62.75 (-2.65%)
DIS   97.89 (-1.52%)
AMC   7.29 (-4.95%)
PYPL   89.04 (-2.28%)
PFE   44.08 (-0.79%)
NFLX   243.83 (-0.56%)
NYSE:NGVT

Ingevity - NGVT Stock Forecast, Price & News

$60.67
-1.19 (-1.92%)
(As of 09/29/2022 11:12 AM ET)
Add
Compare
Today's Range
$59.84
$60.67
50-Day Range
$60.02
$75.11
52-Week Range
$56.31
$83.65
Volume
538 shs
Average Volume
254,983 shs
Market Capitalization
$2.35 billion
P/E Ratio
16.31
Dividend Yield
N/A
Price Target
$82.50

Ingevity MarketRank™ Forecast

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
37.6% Upside
$82.50 Price Target
Short Interest
Bearish
2.49% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.53mentions of Ingevity in the last 14 days
Based on 2 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
15.70%
From $6.05 to $7.00 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.38 out of 5 stars

Basic Materials Sector

77th out of 167 stocks

Chemicals & Allied Products Industry

9th out of 16 stocks

NGVT stock logo

About Ingevity (NYSE:NGVT) Stock

Ingevity Corporation manufactures and sells specialty chemicals and activated carbon materials in North America, the Asia Pacific, Europe, the Middle East, Africa, and South America. The company operates through two segments, Performance Materials and Performance Chemicals. The Performance Materials segment engineers, manufactures, and sells hardwood-based and chemically activated carbon products primarily for use in gasoline vapor emission control systems in cars, motorcycles, trucks, and boats. This segment also produces other activated carbon products for use in various applications, including food, water, beverage, and chemical purification. The Performance Chemicals segment comprises of pavement technologies, industrial specialties, and engineered polymers. It manufactures products derived from crude tall oil and lignin extracted from the kraft pulping process, as well as caprolactone monomers and derivatives derived from cyclohexanone and hydrogen peroxide. This segment's products are used in various applications comprising warm mix paving, pavement preservation, pavement reconstruction and recycling, oil well service additives, oil production, and downstream applications; and adhesives, agrochemical dispersants, lubricants, printing inks, industrial intermediates and oilfield, coatings, resins, elastomers, bioplastics, and medical devices. Ingevity Corporation was founded in 1964 and is headquartered in North Charleston, South Carolina.

Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Stock News Headlines

Ingevity (NGVT) Gains on Demand Strength and Growth Actions
Here's Why Ingevity (NGVT) Looks Ripe for Bottom Fishing
Yet Another Infrastructure Stock You Can Buy - TheStreet
Ingevity (NGVT) Shares Cross Above 200 DMA
See More Headlines
Receive NGVT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Ingevity and its competitors with MarketBeat's FREE daily newsletter.

NGVT Company Calendar

Last Earnings
8/02/2022
Today
9/29/2022
Next Earnings (Estimated)
10/26/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Chemicals & allied products
Sub-Industry
N/A
Previous Symbol
NASDAQ:NGVT
Employees
1,850
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$82.50
High Stock Price Forecast
$84.00
Low Stock Price Forecast
$81.00
Forecasted Upside/Downside
+36.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$118.10 million
Pretax Margin
11.97%

Debt

Sales & Book Value

Annual Sales
$1.39 billion
Cash Flow
$8.22 per share
Book Value
$17.15 per share

Miscellaneous

Free Float
38,476,000
Market Cap
$2.35 billion
Optionable
Optionable
Beta
1.81

Key Executives

  • Mr. John C. Fortson (Age 55)
    Pres, CEO & Director
    Comp: $2.35M
  • Ms. Mary Dean Hall (Age 64)
    Exec. VP & CFO
    Comp: $1.03M
  • Ms. Stacy Lancaster Cozad (Age 51)
    Exec. VP, Gen. Counsel & Sec.
    Comp: $1.39M
  • Mr. Stuart Edward Woodcock Jr.Mr. Stuart Edward Woodcock Jr. (Age 56)
    Exec. VP & Pres of Performance Materials
    Comp: $831.57k
  • Mr. Phillip John Platt (Age 41)
    Chief Accounting Officer, Corp. Controller & VP of Financial Planning
  • Mr. Daniel Gallagher
    VP of Investor Relations
  • John Nypaver
    VP of Treasurer & Investor Relations
  • Ms. Christine Stunyo
    Sr. VP & Chief HR Officer
  • Mr. Richard White (Age 59)
    Sr. VP of Performance Chemicals and Pres of Industrial Specialties & Pavement Technologies
  • Mr. Erik Ripple
    Sr. VP and Chief Growth & Innovation Officer













NGVT Stock - Frequently Asked Questions

Should I buy or sell Ingevity stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Ingevity in the last year. There are currently 2 hold ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" NGVT shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NGVT, but not buy additional shares or sell existing shares.
View NGVT analyst ratings
or view top-rated stocks.

What is Ingevity's stock price forecast for 2022?

2 equities research analysts have issued 1 year price targets for Ingevity's shares. Their NGVT share price forecasts range from $81.00 to $84.00. On average, they predict the company's share price to reach $82.50 in the next year. This suggests a possible upside of 33.4% from the stock's current price.
View analysts price targets for NGVT
or view top-rated stocks among Wall Street analysts.

How have NGVT shares performed in 2022?

Ingevity's stock was trading at $71.70 at the beginning of the year. Since then, NGVT shares have decreased by 13.7% and is now trading at $61.86.
View the best growth stocks for 2022 here
.

When is Ingevity's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, October 26th 2022.
View our NGVT earnings forecast
.

How were Ingevity's earnings last quarter?

Ingevity Co. (NYSE:NGVT) issued its quarterly earnings data on Tuesday, August, 2nd. The company reported $1.73 EPS for the quarter, beating the consensus estimate of $1.68 by $0.05. The company earned $419.90 million during the quarter, compared to the consensus estimate of $406.50 million. Ingevity had a net margin of 9.61% and a trailing twelve-month return on equity of 33.97%.

What guidance has Ingevity issued on next quarter's earnings?

Ingevity issued an update on its FY 2022 earnings guidance on Tuesday, August, 9th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $1.52 billion-$1.65 billion, compared to the consensus revenue estimate of $1.59 billion.

What is John Fortson's approval rating as Ingevity's CEO?

2 employees have rated Ingevity Chief Executive Officer John Fortson on Glassdoor.com. John Fortson has an approval rating of 100% among the company's employees. This puts John Fortson in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Ingevity own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Ingevity investors own include Pfizer (PFE), AbbVie (ABBV), General Electric (GE), Verizon Communications (VZ), WestRock (WRK), Abbott Laboratories (ABT), Boeing (BA), Costco Wholesale (COST), Dominion Energy (D) and Johnson & Johnson (JNJ).

What is Ingevity's stock symbol?

Ingevity trades on the New York Stock Exchange (NYSE) under the ticker symbol "NGVT."

How do I buy shares of Ingevity?

Shares of NGVT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ingevity's stock price today?

One share of NGVT stock can currently be purchased for approximately $61.86.

How much money does Ingevity make?

Ingevity (NYSE:NGVT) has a market capitalization of $2.40 billion and generates $1.39 billion in revenue each year. The company earns $118.10 million in net income (profit) each year or $3.72 on an earnings per share basis.

How many employees does Ingevity have?

The company employs 1,850 workers across the globe.

How can I contact Ingevity?

Ingevity's mailing address is 4920 O`Hear Avenue Suite 400, North Charleston SC, 29406. The official website for the company is www.ingevity.com. The company can be reached via phone at (844) 643-8489, via email at daniel.gallagher@ingevity.com, or via fax at 843-740-8165.

This page (NYSE:NGVT) was last updated on 9/29/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access subscribers can access stock screeners, the Idea Engine, data export tools, research reports, and other premium tools.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.